September 29 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Tuesday that the chairman of its board of directors - Ognyan Donev, and its majority owner - drug maker Sopharma [BUL:3JR], both increased their stakes in the company on September 25.
Sopharma acquired 533,508 Sopharma Trading shares, while Donev acquired 3,114 shares in the drug trader, Sopharma Trading said in two separate bourse filings.
You can subscribe to our M&A newsletter here
Sopharma paid 5 levs ($2.99/2.56 euro) per share, while Donev paid 5.01 levs apiece.
Subsequently, Donev sold 114 shares in Sopharma Trading at a price of 5.35 levs apiece on September 28, the drug trader said in a third separate bourse filing on Tuesday.
At the end of June, Sopharma held a 74.47% stake in Sopharma Trading, while Donev owned directly a stake of under 5%. Ognyan Donev is indirectly the largest shareholder in Sopharma.
As at 14:40 CET on Tuesday, Sopharma Trading shares traded 0.93% higher at 5.4 levs on the Bulgarian Stock Exchange. By the same hour, Sopharma shares traded unchanged at 3.14 levs.
(1 euro = 1.95583 levs)